{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:10:13Z","timestamp":1791925813516,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K08AG064039"],"award-info":[{"award-number":["K08AG064039"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG062421"],"award-info":[{"award-number":["P30AG062421"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG062421"],"award-info":[{"award-number":["P30AG062421"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","award":["AACF-17-524184"],"award-info":[{"award-number":["AACF-17-524184"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","award":["AACF-17-524184-RAPID"],"award-info":[{"award-number":["AACF-17-524184-RAPID"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-021-00123-6","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T05:20:46Z","timestamp":1634016046000},"page":"919-931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0899-7530","authenticated-orcid":false,"given":"Alberto","family":"Serrano-Pozo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-1236","authenticated-orcid":false,"given":"Ayush","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Mezlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-9401","authenticated-orcid":false,"given":"Bradley T.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-6811","authenticated-orcid":false,"given":"Sudeshna","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"123_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"123_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501\u2013518 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"123_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman, E. M. et al. Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 11, 667 (2020).","journal-title":"Nat. Commun."},{"key":"123_CR4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ana.24369","volume":"77","author":"A Serrano-Pozo","year":"2015","unstructured":"Serrano-Pozo, A., Qian, J., Monsell, S. E., Betensky, R. A. & Hyman, B. T. APOE\u03b52 is associated with milder clinical and pathological Alzheimer disease. Ann. Neurol. 77, 917\u2013929 (2015).","journal-title":"Ann. Neurol."},{"key":"123_CR5","doi-asserted-by":"publisher","first-page":"1939\u20131949","DOI":"10.1001\/jama.2015.4669","volume":"313","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele, R. et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA 313, 1939\u20131949 (2015).","journal-title":"JAMA"},{"key":"123_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18198-x","volume":"11","author":"TE Goldberg","year":"2020","unstructured":"Goldberg, T. E., Huey, E. D. & Devanand, D. P. Association of APOE e2 genotype with Alzheimer\u2019s and non-Alzheimer\u2019s neurodegenerative pathologies. Nat. Commun. 11, 4727 (2020).","journal-title":"Nat. Commun."},{"key":"123_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0304-3940(94)91074-X","volume":"175","author":"HL West","year":"1994","unstructured":"West, H. L., Rebeck, G. W. & Hyman, B. T. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci. Lett. 175, 46\u201348 (1994).","journal-title":"Neurosci. Lett."},{"key":"123_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo, A., Das, S. & Hyman, B. T. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20, 68\u201380 (2021).","journal-title":"Lancet Neurol."},{"key":"123_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","volume":"179","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A. et al. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease. Am. J. Pathol. 179, 1373\u20131384 (2011).","journal-title":"Am. J. Pathol."},{"key":"123_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/NEN.0b013e3182933788","volume":"72","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo, A. et al. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J. Neuropathol. Exp. Neurol. 72, 462\u2013471 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"123_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajpath.2015.10.010","volume":"186","author":"A Serrano-Pozo","year":"2016","unstructured":"Serrano-Pozo, A., Betensky, R. A., Frosch, M. P. & Hyman, B. T. Plaque-associated local toxicity increases over the clinical course of Alzheimer disease. Am. J. Pathol. 186, 375\u2013384 (2016).","journal-title":"Am. J. Pathol."},{"key":"123_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin, Y.-T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141\u20131154 (2018).","journal-title":"Neuron"},{"key":"123_CR13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fnins.2017.00702","volume":"11","author":"T Nuriel","year":"2017","unstructured":"Nuriel, T. et al. The endosomal\u2013lysosomal pathway Is dysregulated by APOE4 expression in vivo. Front. Neurosci. 11, 702 (2017).","journal-title":"Front. Neurosci."},{"key":"123_CR14","doi-asserted-by":"crossref","unstructured":"Zhao, N. et al. Alzheimer\u2019s risk factors age, APOE genotype, and sex drive distinct molecular pathways. Neuron 106, 727\u2013742 (2020).","DOI":"10.1016\/j.neuron.2020.02.034"},{"key":"123_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"123_CR16","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 216, 2546\u20132561 (2019).","journal-title":"J. Exp. Med."},{"key":"123_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-020-00394-4","volume":"15","author":"NF Fitz","year":"2020","unstructured":"Fitz, N. F. et al. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice. Mol. Neurodegener. 15, 41 (2020).","journal-title":"Mol. Neurodegener."},{"key":"123_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.stemcr.2019.08.004","volume":"13","author":"H Konttinen","year":"2019","unstructured":"Konttinen, H. et al. PSEN1\u0394E9, APPswe, and APOE4 confer disparate phenotypes in human iPSC-derived microglia. Stem Cell Rep. 13, 669\u2013683 (2019).","journal-title":"Stem Cell Rep."},{"key":"123_CR19","doi-asserted-by":"publisher","unstructured":"Julia, T. C. W. et al. Cholesterol and matrisome pathways dysregulated in human APOE \u03b54 glia. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/713362 (2019).","DOI":"10.1101\/713362"},{"key":"123_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02926-5","volume":"9","author":"M Olah","year":"2018","unstructured":"Olah, M. et al. A transcriptomic atlas of aged human microglia. Nat. Commun. 9, 539 (2018).","journal-title":"Nat. Commun."},{"key":"123_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","volume":"11","author":"I Lefterov","year":"2019","unstructured":"Lefterov, I. et al. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain. Alzheimers Res. Ther. 11, 113 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"123_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-018-0289-x","volume":"13","author":"OJ Conway","year":"2018","unstructured":"Conway, O. J. et al. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans. Mol. Neurodegener. 13, 53 (2018).","journal-title":"Mol. Neurodegener."},{"key":"123_CR23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat. Genet. 49, 1373\u20131384 (2017).","journal-title":"Nat. Genet."},{"key":"123_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0394-9","volume":"9","author":"MC Dalmasso","year":"2019","unstructured":"Dalmasso, M. C. et al. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer\u2019s disease. Transl. Psychiatry 9, 55 (2019).","journal-title":"Transl. Psychiatry"},{"key":"123_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41380-018-0255-6","volume":"24","author":"J-V Haure-Mirande","year":"2019","unstructured":"Haure-Mirande, J.-V. et al. Integrative approach to sporadic Alzheimer\u2019s disease: deficiency of TYROBP in cerebral A\u03b2 amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing A\u03b2 burden. Mol. Psychiatry 24, 431\u2013446 (2019).","journal-title":"Mol. Psychiatry"},{"key":"123_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153, 707\u2013720 (2013).","journal-title":"Cell"},{"key":"123_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/exnr.1994.1108","volume":"128","author":"SH Han","year":"1994","unstructured":"Han, S. H. et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer\u2019s disease and in age-matched controls. Exp. Neurol. 128, 13\u201326 (1994).","journal-title":"Exp. Neurol."},{"key":"123_CR28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"123_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581 (2017).","journal-title":"Immunity"},{"key":"123_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"123_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11295","volume":"7","author":"K Srinivasan","year":"2016","unstructured":"Srinivasan, K. et al. Untangling the brain\u2019s neuroinflammatory and neurodegenerative transcriptional responses. Nat. Commun. 7, 11295 (2016).","journal-title":"Nat. Commun."},{"key":"123_CR32","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1084\/jem.20180653","volume":"215","author":"SS Kang","year":"2018","unstructured":"Kang, S. S. et al. Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau. J. Exp. Med. 215, 2235\u20132245 (2018).","journal-title":"J. Exp. Med."},{"key":"123_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"123_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry, V. H. & Holmes, C. Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 10, 217\u2013224 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"123_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01820-6","volume":"17","author":"R Ismail","year":"2020","unstructured":"Ismail, R. et al. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study. J. Neuroinflammation 17, 151 (2020).","journal-title":"J. Neuroinflammation"},{"key":"123_CR36","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto, T. et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J. Neurosci. 32, 15181\u201315192 (2012).","journal-title":"J. Neurosci."},{"key":"123_CR37","doi-asserted-by":"publisher","first-page":"15163","DOI":"10.1074\/jbc.M114.622209","volume":"290","author":"Y Hori","year":"2015","unstructured":"Hori, Y., Hashimoto, T., Nomoto, H., Hyman, B. T. & Iwatsubo, T. Role of apolipoprotein E in \u0392-amyloidogenesis: isoform-specific effects on protofibril to fibril conversion of A\u03b2 in vitro and brain A\u03b2 deposition in vivo. J. Biol. Chem. 290, 15163\u201315174 (2015).","journal-title":"J. Biol. Chem."},{"key":"123_CR38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"C-C Liu","year":"2017","unstructured":"Liu, C.-C. et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron 96, 1024\u20131032 (2017).","journal-title":"Neuron"},{"key":"123_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"123_CR40","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic, B. et al. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron 100, 1322\u20131336 (2018).","journal-title":"Neuron"},{"key":"123_CR41","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","volume":"28","author":"T Wu","year":"2019","unstructured":"Wu, T. et al. Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep. 28, 2111\u20132123 (2019).","journal-title":"Cell Rep."},{"key":"123_CR42","doi-asserted-by":"publisher","first-page":"eaaf6295","DOI":"10.1126\/scitranslmed.aaf6295","volume":"9","author":"Q Shi","year":"2017","unstructured":"Shi, Q. et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci. Transl. Med. 9, eaaf6295 (2017).","journal-title":"Sci. Transl. Med."},{"key":"123_CR43","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"123_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/tpj.2009.58","volume":"10","author":"DJ Stone","year":"2010","unstructured":"Stone, D. J., Molony, C., Suver, C., Schadt, E. E. & Potter, W. Z. ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer\u2019s disease. Pharmacogenomics J. 10, 161\u2013164 (2010).","journal-title":"Pharmacogenomics J."},{"key":"123_CR45","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1037\/a0031642","volume":"28","author":"L Yu","year":"2013","unstructured":"Yu, L. et al. APOE \u03b54, Alzheimer\u2019s disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol. Aging 28, 1015\u20131023 (2013).","journal-title":"Psychol. Aging"},{"key":"123_CR46","doi-asserted-by":"publisher","first-page":"e2414","DOI":"10.1212\/WNL.0000000000011883","volume":"96","author":"J Qian","year":"2021","unstructured":"Qian, J., Betensky, R. A., Hyman, B. T. & Serrano-Pozo, A. Association of APOE genotype with heterogeneity of cognitive decline rate in Alzheimer disease. Neurology 96, e2414\u2013e2428 (2021).","journal-title":"Neurology"},{"key":"123_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease. N. Engl. J. Med. 368, 117\u2013127 (2013).","journal-title":"N. Engl. J. Med."},{"key":"123_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"123_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"123_CR50","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar, S. et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat. Neurosci. 22, 191\u2013204 (2019).","journal-title":"Nat. Neurosci."},{"key":"123_CR51","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns, C. E. G. et al. TREM2 function impedes tau seeding in neuritic plaques. Nat. Neurosci. 22, 1217\u20131222 (2019).","journal-title":"Nat. Neurosci."},{"key":"123_CR52","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller, S. M. et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol. Neurodegener. 12, 74 (2017).","journal-title":"Mol. Neurodegener."},{"key":"123_CR53","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns, C. E. G. et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc. Natl Acad. Sci. USA 114, 11524\u201311529 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"123_CR54","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1172\/JCI138179","volume":"130","author":"M Gratuze","year":"2020","unstructured":"Gratuze, M. et al. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J. Clin. Invest. 130, 4954\u20134968 (2020).","journal-title":"J. Clin. Invest."},{"key":"123_CR55","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich, J. D. et al. ApoE facilitates the microglial response to amyloid plaque pathology. J. Exp. Med. 215, 1047\u20131058 (2018).","journal-title":"J. Exp. Med."},{"key":"123_CR56","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/NEN.0b013e31825e77de","volume":"71","author":"A Serrano-Pozo","year":"2012","unstructured":"Serrano-Pozo, A. et al. Stable size distribution of amyloid plaques over the course of Alzheimer disease. J. Neuropathol. Exp. Neurol. 71, 694\u2013701 (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"123_CR57","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00401-017-1737-3","volume":"134","author":"J-V Haure-Mirande","year":"2017","unstructured":"Haure-Mirande, J.-V. et al. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer\u2019s pathology. Acta Neuropathol. 134, 769\u2013788 (2017).","journal-title":"Acta Neuropathol."},{"key":"123_CR58","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s41380-018-0258-3","volume":"24","author":"M Audrain","year":"2019","unstructured":"Audrain, M. et al. Integrative approach to sporadic Alzheimer\u2019s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol. Psychiatry 24, 1383\u20131397 (2019).","journal-title":"Mol. Psychiatry"},{"key":"123_CR59","doi-asserted-by":"crossref","unstructured":"Audrain, M. et al. Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP\u2013APOE link in wild-type and Alzheimer\u2019s-related mice. Alzheimers Dement. 17, 149\u2013163 (2021).","DOI":"10.1002\/alz.12256"},{"key":"123_CR60","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu, Y. et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia 60, 559\u2013569 (2012).","journal-title":"Glia"},{"key":"123_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-111","volume":"11","author":"GA Rodriguez","year":"2014","unstructured":"Rodriguez, G. A., Tai, L. M., LaDu, M. J. & Rebeck, G. W. Human APOE4 increases microglia reactivity at A\u03b2 plaques in a mouse model of A\u03b2 deposition. J. Neuroinflammation 11, 111 (2014).","journal-title":"J. Neuroinflammation"},{"key":"123_CR62","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature 575, 669\u2013673 (2019).","journal-title":"Nature"},{"key":"123_CR63","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.celrep.2012.02.014","volume":"1","author":"T Masuda","year":"2012","unstructured":"Masuda, T. et al. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 1, 334\u2013340 (2012).","journal-title":"Cell Rep."},{"key":"123_CR64","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","volume":"22","author":"A Grubman","year":"2019","unstructured":"Grubman, A. et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci. 22, 2087\u20132097 (2019).","journal-title":"Nat. Neurosci."},{"key":"123_CR65","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570, 332\u2013337 (2019).","journal-title":"Nature"},{"key":"123_CR66","doi-asserted-by":"publisher","first-page":"107908","DOI":"10.1016\/j.celrep.2020.107908","volume":"32","author":"Y-W Wan","year":"2020","unstructured":"Wan, Y.-W. et al. Meta-analysis of the Alzheimer\u2019s disease human brain transcriptome and functional dissection in mouse models. Cell Rep. 32, 107908 (2020).","journal-title":"Cell Rep."},{"key":"123_CR67","doi-asserted-by":"crossref","unstructured":"Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).","DOI":"10.1126\/science.aal3222"},{"key":"123_CR68","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman, B. A. et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep. 22, 832\u2013847 (2018).","journal-title":"Cell Rep."},{"key":"123_CR69","doi-asserted-by":"publisher","first-page":"9382","DOI":"10.1073\/pnas.91.20.9382","volume":"91","author":"M Gearing","year":"1994","unstructured":"Gearing, M., Rebeck, G. W., Hyman, B. T., Tigges, J. & Mirra, S. S. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc. Natl Acad. Sci. USA 91, 9382\u20139386 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"123_CR70","doi-asserted-by":"publisher","first-page":"e1008120","DOI":"10.1371\/journal.pcbi.1008120","volume":"16","author":"E Patrick","year":"2020","unstructured":"Patrick, E. et al. Deconvolving the contributions of cell-type heterogeneity on cortical gene expression. PLoS Comput. Biol. 16, e1008120 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"123_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-020-00392-6","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Deciphering cellular transcriptional alterations in Alzheimer\u2019s disease brains. Mol. Neurodegener. 15, 38 (2020).","journal-title":"Mol. Neurodegener."},{"key":"123_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37\u201353 (2016).","journal-title":"Neuron"},{"key":"123_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.142","volume":"5","author":"PL De Jager","year":"2018","unstructured":"De Jager, P. L. et al. A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research. Sci. Data 5, 180142 (2018).","journal-title":"Sci. Data"},{"key":"123_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.185","volume":"5","author":"M Wang","year":"2018","unstructured":"Wang, M. et al. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer\u2019s disease. Sci. Data 5, 180185 (2018).","journal-title":"Sci. Data"},{"key":"123_CR75","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"123_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"123_CR77","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nmeth.2810","volume":"11","author":"B Wang","year":"2014","unstructured":"Wang, B. et al. Similarity network fusion for aggregating data types on a genomic scale. Nat. Methods 11, 333\u2013337 (2014).","journal-title":"Nat. Methods"},{"key":"123_CR78","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma Powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"123_CR79","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Series B Stat. Methodol."},{"key":"123_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","volume":"14","author":"T-PV Huynh","year":"2019","unstructured":"Huynh, T.-P. V. et al. Lack of hepatic apoE does not influence early A\u03b2 deposition: observations from a new APOE knock-in model. Mol. Neurodegener. 14, 37 (2019).","journal-title":"Mol. Neurodegener."},{"key":"123_CR81","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky, J. L. et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159\u2013170 (2004).","journal-title":"Hum. Mol. Genet."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00123-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:05:06Z","timestamp":1725901506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00123-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":81,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["123"],"URL":"https:\/\/doi.org\/10.1038\/s43587-021-00123-6","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}